Table: Fuji Pharmaceutical - 6-MTH group results
May 10 (Reuters)-
Fuji Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Mar 31, 2018 Mar 31, 2017 Sep 30, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 17.96 17.32 38.14
(+3.7 pct) (+2.9 pct) (+7.8 pct)
Operating 2.28 2.27 4.85
(+0.0 pct) (+25.0 pct) (+12.4 pct)
Recurring 2.36 2.54 4.71
(-6.9 pct) (+46.9 pct) (+1.8 pct)
Net 1.74 1.79 3.35
(-2.6 pct) (+66.8 pct) (+1.3 pct)
EPS 116.49 yen 119.60 yen 111.76 yen
Ann Div 48.00 yen
-Q2 div 28.00 yen 23.00 yen
-Q4 div 25.00 yen 14.00 yen
NOTE - Fuji Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T